Marc Schegerin\u2019s arrival inside the CFO office at ArQule is either a fortunate accident or a feat of singular career building precision. For there is little question that ArQule has entered a unique\xa0place in time\xa0along the arc of its existence and it\u2019s this\xa0place in time\xa0that Schegerin has been seeking to reach for more than two decades.
It\u2019s a place where opportunities are quickly realized or lost depending on management\u2019s ability to correctly answer some daunting questions.
\u201cWe have to kind of tease out how much money may be required. When do we spend it? What is the end game where we can we have the biggest impact for the most patients?\u201d says Schegerin, while exposing the coordinates of the intersection of medicine and finance.
Suddenly, Schegerin\u2019s arduous career-building path makes perfect sense. ArQule is the destination where his breadth of experience (From Harvard to Goldman Sachs to Biogen) appears uniquely suited to answer those questions and perhaps many more.\xa0\u2013 Jack Sweeney